Arteriolar Vasodilator [EPC]

Arteriolar Vasodilator [EPC] was reported 78651 times

These side effects are most commonly reported by patients taking drugs of the Arteriolar Vasodilator [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 10493
1 ADVERSE DRUG REACTION 8804
2 ALOPECIA 5803
3 OFF LABEL USE 4166
4 HEADACHE 3871
5 FATIGUE 3698
6 NAUSEA 3141
7 APPLICATION SITE PRURITUS 3039
8 DIZZINESS 2541
9 PAIN 2484
10 DIARRHOEA 2406
11 PRURITUS 2394
12 DYSPNOEA 2075
13 RASH 1975
14 PRODUCT USE IN UNAPPROVED INDICATION 1809
15 ARTHRALGIA 1733
16 INCORRECT DOSE ADMINISTERED 1688
17 OVERDOSE 1685
18 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1680
19 CONDITION AGGRAVATED 1636
20 CONSTIPATION 1575
21 HAIR TEXTURE ABNORMAL 1550
22 FALL 1543
23 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1520
24 APPLICATION SITE PAIN 1493
25 APPLICATION SITE IRRITATION 1466
26 ASTHENIA 1395
27 VOMITING 1387
28 PRODUCT USE ISSUE 1382
29 MALAISE 1374
30 WEIGHT DECREASED 1330
31 COUGH 1271
32 PAIN IN EXTREMITY 1256
33 HYPERSENSITIVITY 1218
34 INSOMNIA 1212
35 ERYTHEMA 1171
36 ANXIETY 1169
37 WEIGHT INCREASED 1116
38 PYREXIA 1112
39 DEPRESSION 1066
40 PRODUCT DOSE OMISSION ISSUE 1038
41 BACK PAIN 1036
42 FEELING ABNORMAL 994
43 ABDOMINAL PAIN 964
44 MUSCLE SPASMS 959
45 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 955
46 PNEUMONIA 944
47 URINARY TRACT INFECTION 912
48 CHEST PAIN 894
49 HYPERTENSION 894
50 PERIPHERAL SWELLING 890
51 SOMNOLENCE 889
52 GAIT DISTURBANCE 879
53 NASOPHARYNGITIS 878
54 APPLICATION SITE ERYTHEMA 844
55 PALPITATIONS 838
56 DECREASED APPETITE 835
57 APPLICATION SITE DRYNESS 833
58 PRODUCT FORMULATION ISSUE 827
59 DRY SKIN 823
60 HYPOAESTHESIA 811
61 PARAESTHESIA 800
62 ANAEMIA 790
63 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 785
64 COVID-19 782
65 HAIR COLOUR CHANGES 781
66 DRUG HYPERSENSITIVITY 768
67 BLOOD PRESSURE INCREASED 762
68 HAIR GROWTH ABNORMAL 747
69 EXPIRED PRODUCT ADMINISTERED 742
70 HYPOTENSION 741
71 ABDOMINAL PAIN UPPER 732
72 DEATH 719
73 BALANCE DISORDER 703
74 PRODUCT QUALITY ISSUE 701
75 INJECTION SITE PAIN 682
76 SINUSITIS 663
77 DYSPEPSIA 660
78 MACULAR DEGENERATION 656
79 HEART RATE INCREASED 648
80 VISION BLURRED 642
81 ABDOMINAL DISCOMFORT 640
82 APPLICATION SITE EXFOLIATION 635
83 TREMOR 633
84 MYALGIA 629
85 SKIN EXFOLIATION 626
86 URTICARIA 616
87 APPLICATION SITE RASH 607
88 CHRONIC KIDNEY DISEASE 606
89 DANDRUFF 603
90 ABDOMINAL DISTENSION 600
91 MEMORY IMPAIRMENT 599
92 INTENTIONAL PRODUCT MISUSE 581
93 CHEST DISCOMFORT 575
94 THERAPEUTIC RESPONSE UNEXPECTED 563
95 MUSCULAR WEAKNESS 561
96 DRUG ADMINISTERED AT INAPPROPRIATE SITE 554
97 MIGRAINE 553
98 OEDEMA PERIPHERAL 542
99 RENAL FAILURE 535
100 UNDERDOSE 525
101 CONTUSION 519
102 GASTROOESOPHAGEAL REFLUX DISEASE 517
103 DRY MOUTH 507
104 JOINT SWELLING 503
105 ACUTE KIDNEY INJURY 501
106 FLUSHING 500
107 STRESS 486
108 WHITE BLOOD CELL COUNT DECREASED 482
109 MOBILITY DECREASED 481
110 INFECTION 476
111 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 475
112 ATRIAL FIBRILLATION 473
113 SWELLING 453
114 MUSCULOSKELETAL STIFFNESS 442
115 OROPHARYNGEAL PAIN 440
116 CHILLS 436
117 EYE PAIN 434
118 VISUAL IMPAIRMENT 433
119 SKIN IRRITATION 431
120 SLEEP DISORDER 430
121 BURNING SENSATION 429
122 DEHYDRATION 428
123 SWELLING FACE 424
124 ILLNESS 423
125 ACCIDENTAL EXPOSURE TO PRODUCT 421
126 NEUROPATHY PERIPHERAL 415
127 EYE IRRITATION 400
128 INFLUENZA 400
129 HOT FLUSH 399
130 DYSPHONIA 392
131 INFUSION RELATED REACTION 389
132 HYPERHIDROSIS 385
133 CARDIAC DISORDER 379
134 HAEMOGLOBIN DECREASED 376
135 HAIR DISORDER 375
136 CONFUSIONAL STATE 374
137 GASTROINTESTINAL DISORDER 372
138 DRY EYE 371
139 DRUG DOSE OMISSION 365
140 ACNE 361
141 INJECTION SITE ERYTHEMA 361
142 PSORIASIS 359
143 COGNITIVE DISORDER 353
144 LOSS OF CONSCIOUSNESS 352
145 SKIN BURNING SENSATION 349
146 ARTHRITIS 347
147 ASTHMA 346
148 SEPSIS 344
149 BRONCHITIS 342
150 MULTIPLE SCLEROSIS RELAPSE 340
151 END STAGE RENAL DISEASE 338
152 PLATELET COUNT DECREASED 336
153 BLOOD GLUCOSE INCREASED 330
154 DRUG INTOLERANCE 329
155 RHEUMATOID ARTHRITIS 328
156 DRUG EFFECT INCOMPLETE 321
157 THROMBOSIS 321
158 NECK PAIN 320
159 INTENTIONAL PRODUCT USE ISSUE 317
160 UPPER RESPIRATORY TRACT INFECTION 316
161 OSTEOARTHRITIS 313
162 RHINORRHOEA 312
163 DRUG INTERACTION 311
164 CONTRAINDICATED PRODUCT ADMINISTERED 310
165 GENERAL PHYSICAL HEALTH DETERIORATION 310
166 PRODUCT CONTAINER ISSUE 307
167 DYSGEUSIA 303
168 POOR QUALITY PRODUCT ADMINISTERED 303
169 HYPERTRICHOSIS 301
170 FLATULENCE 299
171 DYSPNOEA EXERTIONAL 298
172 EPISTAXIS 296
173 BLOOD CREATININE INCREASED 293
174 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 289
175 VERTIGO 288
176 SEIZURE 286
177 HOSPITALISATION 282
178 MYOCARDIAL INFARCTION 282
179 PROCEDURAL PAIN 279
180 TACHYCARDIA 279
181 WHEEZING 276
182 CEREBROVASCULAR ACCIDENT 275
183 DYSPHAGIA 275
184 BLOOD CHOLESTEROL INCREASED 273
185 ERECTILE DYSFUNCTION 273
186 EYE SWELLING 273
187 NASAL CONGESTION 273
188 PULMONARY EMBOLISM 273
189 RASH PRURITIC 273
190 SKIN DISCOLOURATION 273
191 SUICIDAL IDEATION 272
192 FEELING HOT 271
193 SKIN DISORDER 271
194 STOMATITIS 268
195 SYNCOPE 265
196 HAEMATOCHEZIA 263
197 RECTAL HAEMORRHAGE 261
198 DIABETES MELLITUS 260
199 PARAESTHESIA ORAL 260
200 TRICHORRHEXIS 259
201 TOXICITY TO VARIOUS AGENTS 258
202 NO ADVERSE EVENT 256
203 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 255
204 MULTIPLE SCLEROSIS 253
205 CHRONIC SINUSITIS 252
206 COLITIS 252
207 INJECTION SITE BRUISING 251
208 PLEURAL EFFUSION 251
209 BLISTER 250
210 CARDIAC FAILURE CONGESTIVE 250
211 COLITIS ULCERATIVE 250
212 DEPRESSED MOOD 250
213 BONE PAIN 249
214 APPLICATION SITE SCAB 248
215 BLOOD PRESSURE DECREASED 248
216 RENAL IMPAIRMENT 248
217 INFLUENZA LIKE ILLNESS 245
218 UNEVALUABLE EVENT 244
219 FREQUENT BOWEL MOVEMENTS 241
220 NEURALGIA 239
221 SURGERY 239
222 PRODUCTIVE COUGH 235
223 THERAPEUTIC PRODUCT EFFECT DECREASED 234
224 FLUID RETENTION 230
225 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 229
226 CATARACT 228
227 OCULAR HYPERAEMIA 228
228 INJECTION SITE PRURITUS 227
229 ADVERSE EVENT 226
230 HYPONATRAEMIA 222
231 POLLAKIURIA 222
232 DISEASE PROGRESSION 221
233 HEPATIC ENZYME INCREASED 220
234 CELLULITIS 219
235 CORONARY ARTERY DISEASE 218
236 HERPES ZOSTER 216
237 HAEMORRHAGE 215
238 MUSCULOSKELETAL PAIN 214
239 INJECTION SITE SWELLING 213
240 PRODUCT DOSE OMISSION 213
241 THERAPY CESSATION 213
242 OEDEMA 212
243 THROAT IRRITATION 212
244 DEPRESSED LEVEL OF CONSCIOUSNESS 211
245 ORTHOSTATIC HYPOTENSION 211
246 TINNITUS 210
247 DISTURBANCE IN ATTENTION 208
248 ORAL CANDIDIASIS 208
249 ECZEMA 206
250 PAIN OF SKIN 206
251 AMNESIA 205
252 DISCOMFORT 205
253 ARTHROPATHY 203
254 THERAPY INTERRUPTED 202
255 NEPHROLITHIASIS 198
256 PRODUCT SUBSTITUTION ISSUE 198
257 SPEECH DISORDER 195
258 VAGINAL DISCHARGE 193
259 PERICARDIAL EFFUSION 191
260 BLOOD CALCIUM DECREASED 190
261 DRUG EFFECT DECREASED 189
262 SEDATION 188
263 LETHARGY 183
264 EMOTIONAL DISTRESS 182
265 LIMB DISCOMFORT 182
266 SEBORRHOEA 182
267 OXYGEN SATURATION DECREASED 181
268 ASPARTATE AMINOTRANSFERASE INCREASED 179
269 NERVOUSNESS 178
270 EXOSTOSIS 176
271 ASCITES 175
272 SEASONAL ALLERGY 174
273 RED BLOOD CELL COUNT DECREASED 172
274 RADICULOPATHY 171
275 FUNGAL INFECTION 170
276 APPLICATION SITE PAPULES 169
277 ALANINE AMINOTRANSFERASE INCREASED 168
278 CYSTITIS 168
279 THERAPEUTIC RESPONSE DECREASED 167
280 RASH MACULAR 166
281 SECRETION DISCHARGE 166
282 SKIN LESION 166
283 CREATININE RENAL CLEARANCE DECREASED 164
284 APPLICATION SITE VESICLES 163
285 FEMALE GENITAL TRACT FISTULA 163
286 HALLUCINATION 163
287 RASH ERYTHEMATOUS 162
288 SLEEP APNOEA SYNDROME 162
289 GASTROINTESTINAL HAEMORRHAGE 161
290 LACRIMATION INCREASED 161
291 BLOOD POTASSIUM INCREASED 159
292 NEUTROPENIA 159
293 BACTERIAL INFECTION 158
294 IRRITABILITY 158
295 OSTEOPOROSIS 158
296 PROCTITIS 158
297 DYSURIA 157
298 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 157
299 APPLICATION SITE ULCER 156
300 DRUG ADMINISTRATION ERROR 155
301 SEDATION COMPLICATION 155
302 VAGINAL FLATULENCE 155
303 GOUT 154
304 WHITE BLOOD CELL COUNT INCREASED 154
305 JOINT INJURY 153
306 BLOOD POTASSIUM DECREASED 152
307 PANIC ATTACK 152
308 PRODUCT STORAGE ERROR 152
309 MULTIPLE ORGAN DYSFUNCTION SYNDROME 151
310 OBSTRUCTIVE AIRWAYS DISORDER 151
311 OSTEOPENIA 151
312 HYPOTHYROIDISM 150
313 DERMATITIS ATOPIC 149
314 NIGHT SWEATS 149
315 THROMBOCYTOPENIA 149
316 DEVICE ISSUE 148
317 INFLAMMATION 148
318 URINARY INCONTINENCE 147
319 EYE PRURITUS 146
320 LUNG DISORDER 146
321 NEPHROGENIC ANAEMIA 146
322 MICTURITION URGENCY 145
323 RENAL INJURY 145
324 AGITATION 144
325 GAIT INABILITY 144
326 LIBIDO DECREASED 144
327 RENAL DISORDER 144
328 TREATMENT FAILURE 144
329 APPLICATION SITE ACNE 143
330 HEART RATE IRREGULAR 142
331 INJECTION SITE REACTION 142
332 BLOOD PRESSURE FLUCTUATION 141
333 PNEUMOTHORAX 140
334 SENSATION OF FOREIGN BODY 139
335 EOSINOPHILIA 138
336 LOWER RESPIRATORY TRACT INFECTION 138
337 ONYCHOCLASIS 138
338 HEAD INJURY 137
339 BRAIN FOG 135
340 CROHN^S DISEASE 135
341 RASH PAPULAR 134
342 ULCER 134
343 RESTLESSNESS 133
344 INJECTION SITE HAEMORRHAGE 132
345 PHOTOPHOBIA 132
346 EAR PAIN 131
347 INJURY 131
348 JOINT STIFFNESS 131
349 BRAIN NATRIURETIC PEPTIDE INCREASED 130
350 HIP FRACTURE 130
351 MALIGNANT NEOPLASM PROGRESSION 130
352 PLANTAR FASCIITIS 130
353 ROAD TRAFFIC ACCIDENT 130
354 SINUS DISORDER 130
355 EAR INFECTION 129
356 LYMPHOCYTE COUNT DECREASED 129
357 MYASTHENIA GRAVIS 129
358 INCORRECT PRODUCT ADMINISTRATION DURATION 128
359 INTENTIONAL DOSE OMISSION 128
360 PAIN IN JAW 128
361 APPLICATION SITE REACTION 127
362 HYPERLIPIDAEMIA 127
363 DYSARTHRIA 126
364 LYMPHADENOPATHY 126
365 RESTLESS LEGS SYNDROME 126
366 DIVERTICULITIS 125
367 FEELING COLD 125
368 INTERVERTEBRAL DISC PROTRUSION 125
369 OBSTRUCTIVE SLEEP APNOEA SYNDROME 125
370 TRANSIENT ISCHAEMIC ATTACK 125
371 PULMONARY OEDEMA 124
372 SCAB 124
373 BRADYCARDIA 123
374 FIBROMYALGIA 123
375 HAEMORRHOIDS 123
376 LIP SWELLING 123
377 SEXUAL DYSFUNCTION 123
378 CRYING 122
379 VIRAL INFECTION 122
380 BLOOD TEST ABNORMAL 121
381 MYOGLOBIN BLOOD INCREASED 121
382 PRODUCT DOSE OMISSION IN ERROR 121
383 RESPIRATORY FAILURE 121
384 APPLICATION SITE BURN 120
385 ARRHYTHMIA 120
386 BREAST CANCER 120
387 DISORIENTATION 120
388 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 120
389 LIVER DISORDER 120
390 PNEUMONIA ASPIRATION 120
391 PRODUCT PHYSICAL ISSUE 120
392 HYPOACUSIS 119
393 ORAL PAIN 119
394 APPENDICITIS 117
395 DERMATITIS CONTACT 117
396 FEBRILE NEUTROPENIA 117
397 HYPOPHOSPHATAEMIA 117
398 VAGINAL HAEMORRHAGE 117
399 EYE DISORDER 116
400 INTESTINAL OBSTRUCTION 116
401 MOVEMENT DISORDER 116
402 NEUTROPHIL COUNT DECREASED 116
403 BLOOD CALCIUM INCREASED 115
404 DEEP VEIN THROMBOSIS 115
405 HYPERSOMNIA 115
406 APHASIA 114
407 DERMATITIS 114
408 LOCALISED INFECTION 113
409 RESPIRATORY TRACT INFECTION 113
410 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 112
411 AGEUSIA 112
412 BLOOD URIC ACID INCREASED 112
413 HEAD DISCOMFORT 112
414 HEART RATE DECREASED 112
415 NEOPLASM MALIGNANT 111
416 CARDIOGENIC SHOCK 110
417 CYST 110
418 HYPERPHOSPHATAEMIA 110
419 PRODUCT PACKAGING ISSUE 110
420 VENTRICULAR FIBRILLATION 110
421 DIPLOPIA 109
422 HAEMATOCRIT DECREASED 109
423 LIMB INJURY 109
424 PRE-EXISTING CONDITION IMPROVED 109
425 DISEASE RECURRENCE 108
426 PRESYNCOPE 108
427 PSORIATIC ARTHROPATHY 107
428 BLOOD PRESSURE SYSTOLIC INCREASED 106
429 CARDIAC FAILURE 105
430 DYSKINESIA 105
431 HYPERPARATHYROIDISM SECONDARY 105
432 STAPHYLOCOCCAL INFECTION 105
433 PRODUCT PHYSICAL CONSISTENCY ISSUE 104
434 TREATMENT NONCOMPLIANCE 104
435 DRUG PRESCRIBING ERROR 103
436 DYSSTASIA 103
437 FULL BLOOD COUNT DECREASED 103
438 IMPAIRED HEALING 103
439 VITAMIN D DEFICIENCY 102
440 APPENDICOLITH 101
441 BLOOD PRESSURE ABNORMAL 101
442 INJECTION SITE MASS 101
443 LOSS OF LIBIDO 101
444 POOR QUALITY SLEEP 101
445 SPINAL OSTEOARTHRITIS 101
446 ORAL HERPES 100
447 BLOOD PHOSPHORUS INCREASED 99
448 HYPOXIA 99
449 SKIN FISSURES 99
450 THERAPY NON-RESPONDER 99
451 FEAR 98
452 SWOLLEN TONGUE 98
453 TASTE DISORDER 98
454 APPLICATION SITE PARAESTHESIA 97
455 BLOOD GLUCOSE DECREASED 97
456 ERUCTATION 97
457 MIDDLE INSOMNIA 97
458 MOOD SWINGS 97
459 NAIL DISORDER 97
460 ANGER 96
461 DRUG EFFECT LESS THAN EXPECTED 96
462 TROPONIN INCREASED 96
463 DEVICE MALFUNCTION 95
464 ILL-DEFINED DISORDER 95
465 PRODUCT ADMINISTRATION ERROR 95
466 PRURITUS GENERALISED 95
467 SCIATICA 95
468 FAECES DISCOLOURED 94
469 WITHDRAWAL SYNDROME 94
470 WRONG PATIENT RECEIVED MEDICATION 94
471 GASTROENTERITIS VIRAL 93
472 INJECTION SITE RASH 93
473 IRRITABLE BOWEL SYNDROME 93
474 PANCREATITIS 93
475 HAEMOPTYSIS 92
476 MUSCLE TWITCHING 92
477 NOCTURIA 92
478 RETCHING 92
479 INFUSION SITE PAIN 91
480 SKIN ULCER 91
481 THYROID DISORDER 91
482 CARPAL TUNNEL SYNDROME 90
483 CENTRAL NERVOUS SYSTEM LESION 90
484 EXTRA DOSE ADMINISTERED 90
485 FEMUR FRACTURE 90
486 HYPOKALAEMIA 90
487 PRODUCT ADMINISTRATION INTERRUPTED 90
488 HIATUS HERNIA 89
489 IRON DEFICIENCY 89
490 THERAPEUTIC RESPONSE SHORTENED 89
491 EXPOSURE VIA SKIN CONTACT 88
492 HYPERKALAEMIA 88
493 MENTAL DISORDER 88
494 MOOD ALTERED 88
495 BLINDNESS 87
496 BLOOD SODIUM DECREASED 87
497 DEMENTIA 87
498 EMOTIONAL DISORDER 87
499 HEPATIC STEATOSIS 87
500 LIVER FUNCTION TEST INCREASED 87
501 MENTAL IMPAIRMENT 87
502 SWELLING OF EYELID 87
503 THINKING ABNORMAL 87
504 GASTRIC DISORDER 86
505 NIGHTMARE 86
506 PANCYTOPENIA 86
507 PRODUCT USE COMPLAINT 86
508 RESPIRATORY TRACT CONGESTION 86
509 TOOTH DISORDER 86
510 ANGINA PECTORIS 85
511 CHOLELITHIASIS 85
512 INJECTION SITE URTICARIA 85
513 MATERNAL EXPOSURE DURING PREGNANCY 85
514 MEDICATION RESIDUE PRESENT 85
515 MUSCULOSKELETAL DISCOMFORT 85
516 PULMONARY HYPERTENSION 85
517 ROTATOR CUFF SYNDROME 85
518 UPPER LIMB FRACTURE 85
519 WOUND 85
520 BLADDER DISORDER 84
521 CARDIAC ARREST 84
522 INSURANCE ISSUE 84
523 LABORATORY TEST ABNORMAL 84
524 MULTIPLE ALLERGIES 84
525 SCAR 84
526 BLOOD IRON DECREASED 83
527 DEAFNESS NEUROSENSORY 83
528 GASTRITIS 83
529 INCORRECT DRUG ADMINISTRATION DURATION 83
530 RENAL FUNCTION TEST ABNORMAL 83
531 RESPIRATORY DISORDER 83
532 SYSTEMIC LUPUS ERYTHEMATOSUS 83
533 CLOSTRIDIUM DIFFICILE INFECTION 82
534 COMA 82
535 FEELING JITTERY 82
536 FOOT FRACTURE 82
537 MUSCULOSKELETAL CHEST PAIN 82
538 RIB FRACTURE 82
539 ACUTE MYOCARDIAL INFARCTION 81
540 HYPOPHAGIA 81
541 ANALGESIC THERAPY 80
542 ANHEDONIA 80
543 APPLICATION SITE DISCOMFORT 80
544 POST PROCEDURAL COMPLICATION 80
545 TYPE 2 DIABETES MELLITUS 80
546 URINARY RETENTION 80
547 APPLICATION SITE INFLAMMATION 79
548 BLOOD COUNT ABNORMAL 79
549 CANDIDA INFECTION 79
550 FULL BLOOD COUNT ABNORMAL 79
551 GLAUCOMA 79
552 MUSCLE TIGHTNESS 79
553 SLEEP DISORDER THERAPY 79
554 BASAL CELL CARCINOMA 78
555 INCREASED APPETITE 78
556 VITAMIN D DECREASED 78
557 BODY HEIGHT DECREASED 77
558 DRUG THERAPY 77
559 EATING DISORDER 77
560 EYE INFECTION 77
561 INFUSION SITE ERYTHEMA 77
562 KIDNEY INFECTION 77
563 LIGAMENT SPRAIN 77
564 UPPER-AIRWAY COUGH SYNDROME 77
565 PULMONARY MASS 76
566 BACK DISORDER 75
567 C-REACTIVE PROTEIN INCREASED 75
568 EPIGASTRIC DISCOMFORT 75
569 IMPAIRED WORK ABILITY 75
570 OCULAR DISCOMFORT 75
571 SENSORY DISTURBANCE 75
572 SKIN REACTION 75
573 CHROMATURIA 74
574 EXPOSURE DURING PREGNANCY 74
575 HYPERGLYCAEMIA 74
576 MUSCLE SPASTICITY 74
577 NEOPLASM PROGRESSION 74
578 ACCIDENTAL OVERDOSE 73
579 AGGRESSION 73
580 ANKLE FRACTURE 73
581 BLOOD URINE PRESENT 73
582 DRUG WITHDRAWAL SYNDROME 73
583 HYPOGLYCAEMIA 73
584 MEDICATION ERROR 73
585 PRODUCT RESIDUE PRESENT 73
586 THIRST 73
587 ABDOMINAL PAIN LOWER 72
588 ANAPHYLACTIC REACTION 72
589 DEAFNESS 72
590 DRUG ABUSE 72
591 INCREASED TENDENCY TO BRUISE 72
592 MADAROSIS 72
593 PERIORBITAL SWELLING 72
594 SINUS CONGESTION 72
595 SKIN CANCER 72
596 BENIGN PROSTATIC HYPERPLASIA 71
597 SNEEZING 71
598 BRONCHOSPASM 70
599 INCREASED UPPER AIRWAY SECRETION 70
600 LEUKOPENIA 70
601 THROAT TIGHTNESS 70
602 ACUTE RESPIRATORY FAILURE 69
603 HAEMATURIA 69
604 HYPOAESTHESIA ORAL 69
605 IMPAIRED QUALITY OF LIFE 69
606 SKIN LACERATION 69
607 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 69
608 TOOTHACHE 69
609 ASPIRATION 68
610 HAIR INJURY 68
611 HERNIA 68
612 INFUSION SITE SWELLING 68
613 PHOTOSENSITIVITY REACTION 68
614 APPLICATION SITE HAEMORRHAGE 67
615 HYPERCHOLESTEROLAEMIA 67
616 MUSCULOSKELETAL DISORDER 67
617 PLEURAL FIBROSIS 67
618 VITREOUS FLOATERS 67
619 ANGIOEDEMA 66
620 BLOOD ALKALINE PHOSPHATASE INCREASED 66
621 BLOOD MAGNESIUM INCREASED 66
622 CARDIOVASCULAR DISORDER 66
623 CONJUNCTIVITIS 66
624 EAR DISCOMFORT 66
625 GLYCOSYLATED HAEMOGLOBIN INCREASED 66
626 HAEMATOMA 66
627 INITIAL INSOMNIA 66
628 KNEE ARTHROPLASTY 66
629 PLEURAL THICKENING 66
630 APPLICATION SITE HYPERSENSITIVITY 65
631 JOINT RANGE OF MOTION DECREASED 65
632 LOWER LIMB FRACTURE 65
633 SKIN WRINKLING 65
634 TEMPERATURE INTOLERANCE 65
635 COLD SWEAT 64
636 DEVICE DISLOCATION 64
637 PRESBYACUSIS 64
638 PRODUCT COMPLAINT 64
639 SPINAL FRACTURE 64
640 TENDONITIS 64
641 ABNORMAL DREAMS 63
642 APPLICATION SITE DISCOLOURATION 63
643 NODULE 63
644 PRESCRIBED UNDERDOSE 63
645 RENAL FAILURE ACUTE 63
646 TESTICULAR PAIN 63
647 ANAL INCONTINENCE 62
648 ATAXIA 62
649 BLOOD UREA INCREASED 62
650 FEEDING DISORDER 62
651 GLOSSODYNIA 62
652 MASS 62
653 MENTAL STATUS CHANGES 62
654 SKIN HAEMORRHAGE 62
655 HEMIPARESIS 61
656 IMMUNODEFICIENCY 61
657 IMPAIRED GASTRIC EMPTYING 61
658 INTERVERTEBRAL DISC DEGENERATION 61
659 NAIL DISCOLOURATION 61
660 SPINAL STENOSIS 61
661 TRANSAMINASES INCREASED 61
662 BONE DISORDER 60
663 CEREBRAL HAEMORRHAGE 60
664 CHOKING 60
665 COMPLETED SUICIDE 60
666 CONCUSSION 60
667 DECREASED INTEREST 60
668 EYE DISCHARGE 60
669 HYPERTONIC BLADDER 60
670 SPINAL OPERATION 60
671 ADVERSE REACTION 59
672 AORTIC STENOSIS 59
673 APPLICATION SITE SWELLING 59
674 CONVULSION 59
675 FLUID OVERLOAD 59
676 INFUSION SITE HAEMORRHAGE 59
677 PLASMA CELL MYELOMA 59
678 RENAL CYST 59
679 SEPTIC SHOCK 59
680 APHONIA 58
681 PRODUCT PRESCRIBING ERROR 58
682 TENDERNESS 58
683 VISUAL ACUITY REDUCED 58
684 BURSITIS 57
685 MOUTH ULCERATION 57
686 MUSCLE ATROPHY 57
687 PRODUCT PACKAGING QUANTITY ISSUE 57
688 SKIN INFECTION 57
689 BLOOD BILIRUBIN INCREASED 56
690 FOETAL EXPOSURE DURING PREGNANCY 56
691 GALLBLADDER DISORDER 56
692 LARGE INTESTINE POLYP 56
693 PLATELET COUNT INCREASED 56
694 PRODUCT PREPARATION ERROR 56
695 PROTEINURIA 56
696 SKIN TIGHTNESS 56
697 ANTACID THERAPY 55
698 ANTICOAGULANT THERAPY 55
699 BREATH SOUNDS ABNORMAL 55
700 CARDIO-RESPIRATORY ARREST 55
701 FOOT DEFORMITY 55
702 HYPOKINESIA 55
703 MULTIPLE DRUG THERAPY 55
704 PERIPHERAL COLDNESS 55
705 PULMONARY FIBROSIS 55
706 SPUTUM DISCOLOURED 55
707 EAR SWELLING 54
708 GASTRIC ULCER 54
709 METABOLIC ACIDOSIS 54
710 NEEDLE ISSUE 54
711 PRODUCT ADHESION ISSUE 54
712 WRIST FRACTURE 54
713 BLOOD MAGNESIUM DECREASED 53
714 DECREASED ACTIVITY 53
715 PRESCRIBED OVERDOSE 53
716 QUALITY OF LIFE DECREASED 53
717 WEIGHT FLUCTUATION 53
718 ABNORMAL BEHAVIOUR 52
719 CREATININE RENAL CLEARANCE INCREASED 52
720 HEPATIC FUNCTION ABNORMAL 52
721 HYPERAESTHESIA 52
722 HYPERTHYROIDISM 52
723 MUSCLE STRAIN 52
724 SQUAMOUS CELL CARCINOMA OF SKIN 52
725 TENDON RUPTURE 52
726 THERAPEUTIC PRODUCT EFFECT DELAYED 52
727 ACTIVITIES OF DAILY LIVING IMPAIRED 51
728 CEREBRAL INFARCTION 51
729 DELIRIUM 51
730 DRY THROAT 51
731 IMMUNE SYSTEM DISORDER 51
732 RESPIRATORY DISTRESS 51
733 ARTHROPOD BITE 50
734 BLOOD TRIGLYCERIDES INCREASED 50
735 CONGENITAL HIATUS HERNIA 50
736 GROIN PAIN 50
737 PAPULE 50
738 PELVIC PAIN 50
739 PRODUCT LABEL ISSUE 50
740 SCRATCH 50
741 ABASIA 49
742 BODY TEMPERATURE INCREASED 49
743 BREAST PAIN 49
744 DENTAL CARIES 49
745 EYELID PAIN 49
746 INJECTION SITE WARMTH 49
747 LUNG OPACITY 49
748 MALNUTRITION 49
749 MENISCUS INJURY 49
750 NERVE COMPRESSION 49
751 NERVOUS SYSTEM DISORDER 49
752 PALLOR 49
753 SPINAL PAIN 49
754 TOOTH FRACTURE 49
755 TOOTH INFECTION 49
756 VITAMIN B12 DEFICIENCY 49
757 BLOOD ALBUMIN DECREASED 48
758 GASTROINTESTINAL PAIN 48
759 HYPERTENSIVE CRISIS 48
760 IRON DEFICIENCY ANAEMIA 48
761 LEFT VENTRICULAR HYPERTROPHY 48
762 MALIGNANT MELANOMA 48
763 RASH GENERALISED 48
764 TOTAL LUNG CAPACITY DECREASED 48
765 TUBULOINTERSTITIAL NEPHRITIS 48
766 APPLICATION SITE DISCHARGE 47
767 DEVICE EXPULSION 47
768 DEVICE RELATED INFECTION 47
769 KNEE OPERATION 47
770 OBESITY 47
771 ORAL DISCOMFORT 47
772 PERONEAL NERVE PALSY 47
773 ROSACEA 47
774 SARS-COV-2 TEST POSITIVE 47
775 SKIN SWELLING 47
776 SMALL INTESTINAL OBSTRUCTION 47
777 SUICIDE ATTEMPT 47
778 TARDIVE DYSKINESIA 47
779 APATHY 46
780 DIZZINESS POSTURAL 46
781 ECONOMIC PROBLEM 46
782 FOREIGN BODY SENSATION IN EYES 46
783 LOCAL SWELLING 46
784 NASAL DRYNESS 46
785 OROPHARYNGEAL DISCOMFORT 46
786 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 46
787 PARKINSON^S DISEASE 46
788 PLEURITIC PAIN 46
789 PRODUCT AVAILABILITY ISSUE 46
790 REBOUND ACID HYPERSECRETION 46
791 SENSITIVE SKIN 46
792 APPLICATION SITE WARMTH 45
793 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 45
794 DEFORMITY 45
795 DEVICE LEAKAGE 45
796 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 45
797 INTERNATIONAL NORMALISED RATIO INCREASED 45
798 NEPHROGENIC SYSTEMIC FIBROSIS 45
799 PHARYNGITIS 45
800 ANOSMIA 44
801 ARTERIOSCLEROSIS 44
802 DEVICE BREAKAGE 44
803 DIALYSIS 44
804 DYSMENORRHOEA 44
805 FACIAL PAIN 44
806 FACIAL PARALYSIS 44
807 GASTROENTERITIS 44
808 HALLUCINATION, VISUAL 44
809 HUNGER 44
810 IMPAIRED DRIVING ABILITY 44
811 INFUSION SITE DISCHARGE 44
812 NERVE INJURY 44
813 PARALYSIS 44
814 POST PROCEDURAL INFECTION 44
815 PSYCHOTIC DISORDER 44
816 RESPIRATORY SYMPTOM 44
817 TRIGGER FINGER 44
818 GENERALISED OEDEMA 43
819 GINGIVAL BLEEDING 43
820 INTERSTITIAL LUNG DISEASE 43
821 MENSTRUATION IRREGULAR 43
822 PNEUMONITIS 43
823 RENAL PAIN 43
824 TENDON PAIN 43
825 THERMAL BURN 43
826 TOOTH EXTRACTION 43
827 UNRESPONSIVE TO STIMULI 43
828 VENTRICULAR EXTRASYSTOLES 43
829 ABORTION SPONTANEOUS 42
830 FACE OEDEMA 42
831 GASTROINTESTINAL INFECTION 42
832 INTRAOCULAR PRESSURE INCREASED 42
833 JAUNDICE 42
834 OSTEOMYELITIS 42
835 PETECHIAE 42
836 SPLENOMEGALY 42
837 SPONDYLITIS 42
838 WRONG TECHNIQUE IN DRUG USAGE PROCESS 42
839 ATRIAL FLUTTER 41
840 BOWEL MOVEMENT IRREGULARITY 41
841 COVID-19 PNEUMONIA 41
842 EYE INFLAMMATION 41
843 MENORRHAGIA 41
844 NEUTROPHIL COUNT INCREASED 41
845 PRODUCT TASTE ABNORMAL 41
846 SLUGGISHNESS 41
847 BEDRIDDEN 40
848 CEREBRAL DISORDER 40
849 DECUBITUS ULCER 40
850 EYELID OEDEMA 40
851 GLOMERULAR FILTRATION RATE DECREASED 40
852 HORMONE LEVEL ABNORMAL 40
853 HYPERCALCAEMIA 40
854 LEUKOCYTOSIS 40
855 WALKING AID USER 40
856 ASTHENOPIA 39
857 BACK INJURY 39
858 BREAST CANCER FEMALE 39
859 BREAST MASS 39
860 BRONCHIECTASIS 39
861 CARDIOMEGALY 39
862 CARDIOMYOPATHY 39
863 DELUSION 39
864 DIVERTICULUM 39
865 HEREDITARY ANGIOEDEMA 39
866 HYPERKERATOSIS 39
867 LARYNGITIS 39
868 MALIGNANT MELANOMA STAGE 0 39
869 NEPHROPATHY 39
870 PULMONARY CONGESTION 39
871 RELAPSING-REMITTING MULTIPLE SCLEROSIS 39
872 THERAPY CHANGE 39
873 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 39
874 ACCIDENT 38
875 BLOOD GLUCOSE ABNORMAL 38
876 DERMATITIS ALLERGIC 38
877 EJECTION FRACTION DECREASED 38
878 EPILEPSY 38
879 FLANK PAIN 38
880 HAEMATEMESIS 38
881 HIP ARTHROPLASTY 38
882 NEOPLASM 38
883 OSTEOSCLEROSIS 38
884 PRODUCT ODOUR ABNORMAL 38
885 SEBORRHOEIC DERMATITIS 38
886 TOOTH ABSCESS 38
887 URINE OUTPUT DECREASED 38
888 AFFECTIVE DISORDER 37
889 APHTHOUS ULCER 37
890 ATELECTASIS 37
891 BARRETT^S OESOPHAGUS 37
892 CARDIAC TAMPONADE 37
893 EYELID PTOSIS 37
894 FOLLICULITIS 37
895 PARANOIA 37
896 PHARYNGEAL SWELLING 37
897 PHARYNGITIS STREPTOCOCCAL 37
898 RENAL FAILURE CHRONIC 37
899 RESPIRATORY SYNCYTIAL VIRUS INFECTION 37
900 SPINAL DISORDER 37
901 VARICOSE VEIN 37
902 ACTINIC KERATOSIS 36
903 ALTERED STATE OF CONSCIOUSNESS 36
904 AORTIC ARTERIOSCLEROSIS 36
905 BLOOD THYROID STIMULATING HORMONE INCREASED 36
906 BODY TEMPERATURE DECREASED 36
907 CARBOHYDRATE ANTIGEN 125 INCREASED 36
908 CARDIAC FLUTTER 36
909 DIABETIC KETOACIDOSIS 36
910 DISABILITY 36
911 ESSENTIAL HYPERTENSION 36
912 FEELING DRUNK 36
913 GRIP STRENGTH DECREASED 36
914 GYNAECOMASTIA 36
915 INCONTINENCE 36
916 INFUSION SITE PRURITUS 36
917 MEAN CELL VOLUME INCREASED 36
918 PHARYNGEAL OEDEMA 36
919 POOR VENOUS ACCESS 36
920 PRODUCT DISTRIBUTION ISSUE 36
921 SJOGREN^S SYNDROME 36
922 SKIN ATROPHY 36
923 SPINAL COMPRESSION FRACTURE 36
924 SUPRAVENTRICULAR TACHYCARDIA 36
925 BIPOLAR DISORDER 35
926 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 35
927 CLOSTRIDIUM DIFFICILE COLITIS 35
928 DRUG DEPENDENCE 35
929 HYPOCALCAEMIA 35
930 HYSTERECTOMY 35
931 INJECTION SITE DISCOLOURATION 35
932 LOW DENSITY LIPOPROTEIN INCREASED 35
933 LUNG NEOPLASM MALIGNANT 35
934 NASAL DISCOMFORT 35
935 ONYCHOMYCOSIS 35
936 ORAL MUCOSAL BLISTERING 35
937 PANCREATITIS ACUTE 35
938 PERIORBITAL OEDEMA 35
939 PRODUCT CLOSURE REMOVAL DIFFICULT 35
940 URINE ABNORMALITY 35
941 UROSEPSIS 35
942 VULVOVAGINAL BURNING SENSATION 35
943 AUTOIMMUNE DISORDER 34
944 BLOOD TESTOSTERONE DECREASED 34
945 BONE CYST 34
946 BREAST TENDERNESS 34
947 CONTRAINDICATION TO MEDICAL TREATMENT 34
948 CORONARY ARTERY OCCLUSION 34
949 DEVICE USE ISSUE 34
950 EAR PRURITUS 34
951 ENERGY INCREASED 34
952 FAECES SOFT 34
953 FORMICATION 34
954 GINGIVAL PAIN 34
955 HEPATIC FAILURE 34
956 HEPATITIS 34
957 OVARIAN CYST 34
958 PRODUCT DISPENSING ERROR 34
959 RHABDOMYOLYSIS 34
960 SKIN HYPERPIGMENTATION 34
961 SKIN WARM 34
962 SOMNAMBULISM 34
963 WRONG DRUG ADMINISTERED 34
964 AORTIC VALVE INCOMPETENCE 33
965 BLINDNESS UNILATERAL 33
966 COMPLICATION ASSOCIATED WITH DEVICE 33
967 FOOD POISONING 33
968 INJECTION SITE INDURATION 33
969 LIVER FUNCTION TEST ABNORMAL 33
970 MOUTH SWELLING 33
971 OESOPHAGITIS 33
972 PARANASAL SINUS DISCOMFORT 33
973 PELVIC FRACTURE 33
974 PULMONARY ARTERIAL HYPERTENSION 33
975 SCOLIOSIS 33
976 SENSORY LOSS 33
977 SINUS TACHYCARDIA 33
978 SKIN ABRASION 33
979 SNORING 33
980 THERAPY PARTIAL RESPONDER 33
981 UTERINE LEIOMYOMA 33
982 WOUND INFECTION 33
983 ARTERIOSCLEROSIS CORONARY ARTERY 32
984 ATRIOVENTRICULAR BLOCK 32
985 BLOOD CHOLESTEROL ABNORMAL 32
986 BLOOD PRESSURE DIASTOLIC ABNORMAL 32
987 BLOOD THYROID STIMULATING HORMONE DECREASED 32
988 CENTRAL SEROUS CHORIORETINOPATHY 32
989 DIVERTICULUM INTESTINAL 32
990 EYE HAEMORRHAGE 32
991 FRUSTRATION TOLERANCE DECREASED 32
992 FUNGAL SKIN INFECTION 32
993 GAIT SPASTIC 32
994 GLUCOSE TOLERANCE IMPAIRED 32
995 MELANOCYTIC NAEVUS 32
996 PHOTOPSIA 32
997 PNEUMONIA BACTERIAL 32
998 PSEUDOMONAS INFECTION 32
999 PULMONARY THROMBOSIS 32